What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Feline Upper Respiratory Infections: Causes, Transmission, and Treatment

Introduction

Feline upper respiratory tract infection (URI) represents a multifactorial syndrome of significant morbidity in domestic cat populations worldwide [1, 2]. The disease complex is characterized by inflammation of the nasal passages, pharynx, larynx, trachea, and conjunctiva, with etiological agents spanning both viral and bacterial pathogens [3, 4]. Feline herpesvirus type 1 (FHV-1) and feline calicivirus (FCV) are the most frequently implicated viral agents, while Chlamydia felis, Mycoplasma felis, and Bordetella bronchiseptica constitute the primary bacterial contributors [2, 5, 6]. The clinical and economic burden of URI is particularly pronounced in shelter environments, where high population density, stress, and turnover rates facilitate rapid pathogen dissemination [3, 7, 8]. This article provides an exhaustive review of the etiology, transmission mechanisms, clinical pathology, diagnostic approaches, treatment protocols, and control strategies for feline upper respiratory infections, with a focus on bacterial components and their interactions within the respiratory microbiome.

Etiology and Pathogen Profiles

Viral Pathogens

FHV-1, a double-stranded DNA virus of the family Herpesviridae, is a primary cause of feline viral rhinotracheitis [1, 9]. The virus exhibits tropism for the epithelial cells of the upper respiratory tract and conjunctiva, leading to acute necrotizing rhinitis and conjunctivitis [10]. Following acute infection, FHV-1 establishes latency in the trigeminal ganglia, with reactivation possible during periods of stress or immunosuppression [4, 11]. FCV, a single-stranded RNA virus of the family Caliciviridae, is characterized by high genetic diversity and antigenic variability [12, 5]. FCV infection typically manifests with oral ulceration, salivation, and milder respiratory signs compared to FHV-1 [1, 9]. Co-infections with both viruses occur in a measurable proportion of cases, with one study reporting a mixed infection rate of 6.7% among clinically affected cats [1].

Bacterial Pathogens

Chlamydia felis is an obligate intracellular Gram-negative bacterium that primarily causes conjunctivitis, often with minimal upper respiratory involvement [12, 13]. The organism infects conjunctival epithelial cells, leading to follicular conjunctivitis and chemosis [10]. Mycoplasma felis is a cell wall-deficient bacterium that colonizes the mucosal surfaces of the upper respiratory tract and conjunctiva [6, 13]. Its role as a primary pathogen is debated, but it is frequently detected in co-infections with FCV or FHV-1 [5, 6]. Bordetella bronchiseptica is a Gram-negative coccobacillus that causes tracheobronchitis and is a notable pathogen in shelter populations, particularly in kittens [2, 14]. The bacterium adheres to ciliated respiratory epithelium, disrupting mucociliary clearance and facilitating secondary infections [14].

How Do Cats Get Respiratory Infections

Transmission of feline URI pathogens occurs primarily through direct contact with infected individuals or fomites [2, 8]. Aerosolized droplets generated by sneezing and coughing are the principal route for viral and bacterial dissemination over short distances [3, 15]. Indirect transmission via contaminated food bowls, bedding, litter boxes, and human hands is well documented, particularly in shelter and multi-cat household settings [7, 8]. FHV-1 is shed in ocular, nasal, and oral secretions, with latency carriers serving as a persistent source of infection during reactivation episodes [4, 11]. FCV is shed in oral secretions and can persist in the environment for up to one month under favorable conditions [9]. Bacterial pathogens such as B. bronchiseptica are shed in respiratory secretions and can survive in the environment for several days [14]. The incubation period ranges from 2 to 10 days depending on the pathogen and host immune status [4, 10].

Are Cat Respiratory Infections Dangerous

The clinical severity of feline URI ranges from mild, self-limiting disease to severe, life-threatening illness, particularly in kittens, geriatric cats, and immunocompromised individuals [1, 16]. Complications include chronic rhinosinusitis, corneal ulceration (secondary to FHV-1 keratitis), pneumonia, and systemic infection [10, 17]. In shelter populations, URI is a leading cause of morbidity and a significant contributor to euthanasia due to prolonged treatment duration and resource constraints [2, 3, 18]. A study of 43,431 feline shelter entries found that male cats were 1.24 times more likely to be classified as URI-positive compared to females, and cats older than 4 months were twice as likely to be positive compared to kittens [3]. The case fatality rate varies by pathogen, with FCV-associated virulent systemic disease carrying a high mortality rate in some outbreaks [5, 9].

Is Cat Respiratory Infection Contagious to Humans

The zoonotic potential of feline URI pathogens is limited but not absent. Bordetella bronchiseptica is a known zoonotic agent, capable of causing respiratory disease in immunocompromised humans, though transmission from cats to humans is rare [2, 14]. Chlamydia felis has been reported to cause conjunctivitis in humans following direct contact with infected ocular secretions, but human-to-human transmission is not documented [12, 13]. FHV-1 and FCV are species-specific and do not infect humans [4, 9]. Standard hygiene practices, including hand washing after handling infected cats and avoiding direct contact with ocular or nasal discharge, are sufficient to mitigate zoonotic risk [14, 10]. For a broader discussion of zoonotic considerations, refer to the article on Feline Respiratory Infections: Causes, Transmission, and Zoonotic Risk.

Clinical Signs and Pathology

Clinical signs of feline URI are largely determined by the specific pathogen involved and the host's immune status [1, 6]. Common signs include serous to mucopurulent nasal discharge, sneezing, conjunctivitis, ocular discharge, and pyrexia [4, 10]. FHV-1 infection is classically associated with severe conjunctivitis, corneal dendritic ulcers, and profuse serous ocular discharge that progresses to mucopurulent [10, 9]. FCV infection is characterized by oral ulceration on the tongue, hard palate, and lips, along with milder ocular signs [1, 5]. C. felis infection typically presents with marked conjunctival hyperemia and chemosis, often without significant nasal involvement [12, 13]. M. felis is frequently detected in cats with chronic conjunctivitis and rhinitis [6, 35]. B. bronchiseptica infection is associated with a harsh, honking cough and mucopurulent nasal discharge, particularly in kittens [14, 19].

Pathological findings include mucosal hyperemia, edema, and necrosis of the nasal turbinates and conjunctival epithelium [10, 9]. In chronic cases, fibrosis and adhesion formation within the nasal passages can lead to permanent obstruction and secondary bacterial sinusitis [17, 35]. The gut and respiratory microbiomes have been shown to differ between cats with chronic clinical signs and clinically normal cats, suggesting a role for microbial community structure in disease persistence [35].

Diagnostic Approaches

Molecular Diagnostics

Polymerase chain reaction (PCR) and reverse transcription PCR (RT-PCR) are the gold standard methods for detecting FHV-1 and FCV, respectively, due to their high sensitivity and specificity [1, 20, 21]. Real-time PCR panels that simultaneously detect FHV-1, FCV, C. felis, M. felis, and B. bronchiseptica are widely used in diagnostic laboratories [6, 20]. A study of 453 respiratory panel submissions found an overall positivity rate of 69.3%, with Mycoplasma species being the most frequent single detection (36.9%) and FCV plus Mycoplasma species being the most common co-detection (20.4%) [6]. Sample types include conjunctival, nasal, and oropharyngeal swabs, with conjunctival swabs being the most common sampling site [2, 22].

Serology and Culture

Serological assays, such as enzyme-linked immunosorbent assays (ELISAs), are available for detecting antibodies against FHV-1 and FCV, but their utility is limited by prior vaccination and the inability to distinguish active infection from past exposure [4, 23]. Bacterial culture for B. bronchiseptica and C. felis is possible but less sensitive than PCR and requires specialized media [14, 13]. Antimicrobial susceptibility testing is recommended for bacterial isolates to guide antibiotic selection, particularly in refractory cases [24, 13].

Imaging and Endoscopy

Radiography and computed tomography (CT) are used to evaluate chronic rhinosinusitis and identify structural abnormalities such as nasal turbinate destruction or foreign bodies [17, 25]. Rhinoscopy allows direct visualization of the nasal mucosa and collection of biopsy samples for histopathology and PCR [17].

Treatment Strategies

Antimicrobial Therapy

Antibiotic selection for bacterial URI should be guided by culture and susceptibility results when possible [24, 13]. Doxycycline is the first-line treatment for C. felis and M. felis infections, with a typical course of 7 to 14 days [26, 13]. Pradofloxacin, a third-generation fluoroquinolone, has demonstrated efficacy against both C. felis and M. felis and is approved for feline use [13]. Marbofloxacin has been evaluated in field studies for the treatment of feline URI, showing clinical improvement in a majority of cases [24]. B. bronchiseptica is often susceptible to doxycycline, tetracycline, and potentiated sulfonamides, but resistance to beta-lactams is common [14, 19]. The combination of Yin Qiao San (a Chinese herbal formula) with antibiotics (amoxicillin-clavulanate or doxycycline) has been shown to result in faster clinical improvement compared to antibiotics alone in shelter cats [27].

Antiviral Therapy

Antiviral agents for FHV-1 include famciclovir, a prodrug that is converted to penciclovir and inhibits viral DNA polymerase [28, 11]. Famciclovir is administered orally and has been shown to reduce clinical signs and viral shedding in experimentally infected cats [11]. Topical ophthalmic antivirals, such as cidofovir and trifluridine, are used for FHV-1-associated keratitis and conjunctivitis [10]. Interferon-omega has been evaluated as an adjunctive therapy, with intranasal administration showing some benefit in chronic cases [29].

Supportive Care

Supportive care is critical for managing feline URI, particularly in shelter settings [26, 30]. Measures include nutritional support (appetite stimulants, assisted feeding), fluid therapy to correct dehydration, and humidification to soothe irritated airways [28, 31]. Ocular lubricants and topical antibiotics are used to manage conjunctivitis and prevent corneal damage [10]. Nebulization with saline or antimicrobial solutions can help liquefy nasal secretions and improve breathing [30, 25].

Control and Prevention

Vaccination

Core vaccination against FHV-1 and FCV is recommended for all cats, with modified live or inactivated vaccines available for parenteral administration [4, 9]. Intranasal vaccines provide rapid local immunity and are particularly useful in shelter environments [29]. However, antigenic drift in FCV can lead to vaccine failure, as circulating strains may be phylogenetically distant from vaccine strains (e.g., F9 and 255) [5]. A study in China found that the F9 vaccine strain was distantly related to local FCV isolates, suggesting the need for geographically specific vaccine development [5].

Environmental Management

In shelters, reducing stress through appropriate housing, enrichment, and minimal handling is associated with lower URI incidence [7, 15]. Cats that did not develop URI were handled significantly more frequently than those that did (1.1 vs. 0.7 times per day), suggesting that positive human interaction may reduce stress and bolster immune function [7]. Environmental disinfection with bleach (1:32 dilution) or accelerated hydrogen peroxide products is effective against FHV-1, FCV, and bacterial pathogens [8, 15]. Isolation of infected cats and cohorting of new arrivals are essential to limit transmission [2, 8].

Biosecurity

Strict hand hygiene, use of dedicated equipment for each cat, and disinfection of shared surfaces are critical for preventing fomite transmission [8, 15]. Quarantine periods of 7 to 14 days for new arrivals allow for observation and early detection of clinical signs [2, 18]. For a detailed discussion of diagnostic panels, refer to the article on Respiratory Virus Panels in Dogs and Cats.

Diagnostic and Treatment Decision Framework

The following Mermaid diagram outlines a clinical decision tree for the management of feline upper respiratory infections.

flowchart TD
    A[Cat presents with URI signs], > B{Clinical severity assessment}
    B, >|Mild| C[Supportive care + monitoring]
    B, >|Moderate to severe| D[Collect conjunctival/nasal swabs]
    D, > E[PCR panel: FHV-1, FCV, C. felis, M. felis, B. bronchiseptica]
    E, > F{Pathogen identified?}
    F, >|FHV-1| G[Famciclovir + supportive care]
    F, >|FCV| H[Supportive care + +/- antivirals]
    F, >|C. felis or M. felis| I[Doxycycline or pradofloxacin]
    F, >|B. bronchiseptica| J[Doxycycline or potentiated sulfonamides]
    F, >|Mixed infection| K[Treat all identified pathogens]
    F, >|No pathogen detected| L[Empiric doxycycline + supportive care]
    G, > M[Re-evaluate in 7-14 days]
    H, > M
    I, > M
    J, > M
    K, > M
    L, > M
    M, > N{Clinical improvement?}
    N, >|Yes| O[Continue treatment until resolution]
    N, >|No| P[Advanced diagnostics: culture, imaging, rhinoscopy]
    P, > Q[Adjust therapy based on results]

Conclusion

Feline upper respiratory infections remain a significant challenge in veterinary medicine, particularly in shelter and multi-cat environments. The disease complex involves a dynamic interplay between viral and bacterial pathogens, with FHV-1, FCV, C. felis, M. felis, and B. bronchiseptica as the primary etiological agents. Transmission occurs via direct contact, aerosolized droplets, and fomites, with stress and high population density acting as major risk factors. While most infections are self-limiting, severe disease can occur in vulnerable populations, and chronic sequelae are common. Diagnosis relies on molecular methods such as PCR, with treatment guided by pathogen identification and antimicrobial susceptibility testing. Vaccination, environmental management, and biosecurity measures are essential for control. Ongoing surveillance and research into pathogen evolution, microbiome interactions, and novel therapeutics are needed to reduce the burden of this disease.

References

[1] El-Zaky N, Orieby A, Tahoun A, et al. A study on Feline Upper Respiratory Tract Disease with Clinico-molecular Profiling of the associated Feline Herpesvirus and Calicivirus Infections in Domestic Cats. Egyptian Journal of Veterinary Sciences. 2025. URL: https://www.semanticscholar.org/paper/b640b2d235ece152aed3f9e499ce4fa4ef18e522

[2] Kennedy U, Paterson M, Magalhães RS, et al. A Scoping Review of the Evidence on Prevalence of Feline Upper Respiratory Tract Infections and Associated Risk Factors. Veterinary Sciences. 2024. URL: https://www.semanticscholar.org/paper/685f7bae8b2e6277c13d110680b4306640221d0b

[3] Kennedy U, Paterson M, Clark N. Epidemiological insights into the burden of feline upper respiratory tract infections in Queensland RSPCA shelters. Australian Veterinary Journal. 2023. URL: https://www.semanticscholar.org/paper/ab374a3515fcd302c45a6002b14b06d49bc40af7

[4] Lappin M. Feline upper respiratory infections. 2015. URL: https://www.semanticscholar.org/paper/8f7131652e72bc80fb0992f0ed34c58ae0cb03d8

[5] Gao J, Li Y, Xie Q, et al. Epidemiological Investigation of Feline Upper Respiratory Tract Infection Encourages a Geographically Specific FCV Vaccine. Veterinary Sciences. 2023. URL: https://www.semanticscholar.org/paper/9f25812d23ad3fa275d5f8aee597cf6b799f8600

[6] Neely D, Mosley YYC, Morris S, et al. Feline ocular and respiratory infections: a retrospective analysis of clinical cases submitted to Georgia Veterinary Diagnostic Laboratories (2012–2022). JFMS open reports. 2025. URL: https://www.semanticscholar.org/paper/be7160ab3f31934a9ec27b177490872d8eda0100

[7] Burns CC, Redding L, Watson B. The Effects of Frequency and Duration of Handling on the Development of Feline Upper Respiratory Infections in a Shelter Setting. Animals. 2020. URL: https://www.semanticscholar.org/paper/e132925bc861dc704b4a9615b06f42795f997ab0

[8] August J. The control and eradication of feline upper respiratory infections in cluster populations. 1990. URL: https://www.semanticscholar.org/paper/52c058951e64ea247193f994103a97c03a32b532

[9] Sykes J. Feline Upper Respiratory Tract Pathogens: Herpesvirus-1 and Calicivirus. 2001. URL: https://www.semanticscholar.org/paper/6982ffdb64125b9d151650385fa2d02afa87d963

[10] Charnock L, Vernau KM, Burkitt-Creedon J, et al. Clinical Management of Ophthalmic Manifestations of Upper Respiratory Tract Infections in Kittens. The Veterinary clinics of North America. Small animal practice. 2026. URL: https://www.semanticscholar.org/paper/7e1ccd8a97abba90473468b250a1e4b2e613d96d

[11] Contreras ET. Assessment of novel strategies for the prevention and treatment of feline upper respiratory tract infections in shelters and feline herpesvirus-1 in laboratory settings. 2019. URL: https://www.semanticscholar.org/paper/cf09a3afb9993c113a8a4e02c4a07f8af821ab04

[12] Mochizuki M, Kawakami K, Hashimoto M, et al. Recent epidemiological status of feline upper respiratory infections in Japan. Journal of Veterinary Medical Science. 2000. URL: https://www.semanticscholar.org/paper/09cb8bcf6e49dfcacbc8458a4aff810770bf789e

[13] Hartmann A, Helps C, Lappin M, et al. Efficacy of pradofloxacin in cats with feline upper respiratory tract disease due to Chlamydophila felis or Mycoplasma infections. Journal of Veterinary Internal Medicine. 2008. URL: https://www.semanticscholar.org/paper/57afa23450c31f5339f613ff606562c5d5fce260

[14] Litster A. FELINE UPPER RESPIRATORY TRACT INFECTIONS: A REVIEW OF PATHOGENS AND THERAPEUTICS. 2015. URL: https://www.semanticscholar.org/paper/3d377855aca2ed6262e0037da9b2e1f6848c851d

[15] Fowler K. Control of feline upper respiratory infections in animal shelters. 2002. URL: https://www.semanticscholar.org/paper/5d73dddb5a55961cf8fcfc358ca1aeb351baba40

[16] Anggraeni HE, Primayani R, Nihaya K. Prevalence of Upper Respiratory Tract Infection in Cats at Satwagia Intensive Care Bogor. Journal of Applied Veterinary Science and Technology. 2025. URL: https://www.semanticscholar.org/paper/12d88f7b4d2143431cfb616485e138e685f8abdc

[17] Scherk M. Snots and Snuffles: Rational Approach to Chronic Feline Upper Respiratory Syndromes. Journal of feline medicine and surgery. 2010. URL: https://www.semanticscholar.org/paper/82c9180f54e4247fdda0b457153d7f79394e289a

[18] Kennedy U. Epidemiology of feline upper respiratory tract infections in shelter cats at RSPCA Queensland. URL: https://www.semanticscholar.org/paper/2ec20ecb69c45d9fa109dbb5b19822a6d08703ce

[19] Bradley A, Kinyon J, Frana T, et al. Diagnosis, Treatment & Prevention of Feline Upper Respiratory Tract Infections. 2012. URL: https://www.semanticscholar.org/paper/1b8dc33e610e766d3462862970d89cf2b152e594

[20] Litster A, Wu CC, Leutenegger C. Detection of feline upper respiratory tract disease pathogens using a commercially available real-time PCR test. The Veterinary Journal. 2015. URL: https://www.semanticscholar.org/paper/572c2b3baf1bc566231a2bd527c43a4878fcca94

[21] Ju H, Yang D, Jin J, et al. Spectrum detection and analysis of the epidemiological characteristics of infectious pathogens in the feline respiratory tract. Archives of Virology. 2024. URL: https://www.semanticscholar.org/paper/e0c1ed3785ff7226469cf3390ef8590e7b09bad9

[22] Doğan F, Acar G, Fedai T, et al. Investigation of the presence of gammaherpesvirus infections in cats with and without upper respiratory tract disease. Comparative Immunology, Microbiology & Infectious Diseases. 2026. URL: https://www.semanticscholar.org/paper/45e196723ff63c871060cdd020c16f154918d9cf

[23] Quimby J, Lappin M. Feline focus: Update on feline upper respiratory diseases: introduction and diagnostics. Compendium. 2009. URL: https://www.semanticscholar.org/paper/82d2d84adb723cd366f5b6a4cd6b0b94fcf02c3c

[24] Dossin O, Gruet P, Thomas E. Comparative field evaluation of marbofloxacin tablets in the treatment of feline upper respiratory infections. Journal of Small Animal Practice. 1998. URL: https://www.semanticscholar.org/paper/91fd62cf6afcd4179d4d9a15cc5ec547506bad59

[25] Hartmann K. FELINE UPPER RESPIRATORY TRACT INF

[26] Hartmann K. Feline upper respiratory tract infections – current treatment strategies. 2017. URL: https://www.semanticscholar.org/paper/528e7bbd84b8ab986fb84dbcb03b1f2da1734a9d

[27] Hirsch DA, Shiau D, Xie H. A Randomized and Controlled Study of the Efficacy of Yin Qiao San Combined with Antibiotics Compared to Antibiotics Alone for the Treatment of Feline Upper Respiratory Disease. American journal of traditional Chinese veterinary medicine. 2017. URL: https://www.semanticscholar.org/paper/3d4699e3669f105cb8d99ed3fd84fabc3f67f293

[28] Lappin M. Update on the management of feline upper respiratory infections. 2015. URL: https://www.semanticscholar.org/paper/2341b3c8c3d6c6d443b8414bde6994dfcf298f5e

[29] Fenimore A, Carter K, Fankhauser J, et al. Evaluation of intranasal vaccine administration and high-dose interferon-α2b therapy for treatment of chronic upper respiratory tract infections in shelter cats. Journal of feline medicine and surgery. 2016. URL: https://www.semanticscholar.org/paper/f2b3c3552378e39c0ac3ac1813f4c8a3d03e7934

[30] Lappin M. Management of Feline Upper Respiratory Infections II. 2014. URL: https://www.semanticscholar.org/paper/b1f583acaf562c742267fc6efc4060066ad746d9

[31] Fenimore A. Update on the Diagnosis, Treatment and Prevention of Feline Upper Respiratory Infections Sponsored By Boehringer Ingelheim. 2014. URL: https://www.semanticscholar.org/paper/ef6ba6d901ecfb290201f1c4576fa519a7c207f7

[32] Fenimore A. Update on the Diagnosis, Treatment, and Prevention of Feline Upper Respiratory Tract Infections. 2013. URL: https://www.semanticscholar.org/paper/1a93b02d05fca379eee17ad8501e48d9f3c0fdcb

[33] Spindel M, Slater M, Boothe D. A survey of North American shelter practices relating to feline upper respiratory management. Journal of feline medicine and surgery. 2013. URL: https://www.semanticscholar.org/paper/c370151cb62ab2dd950d7c6bc2e646a96719be23

[34] Quimby J, Lappin M. Feline focus: Update on feline upper respiratory diseases: condition-specific recommendations. Compendium. 2010. URL: https://www.semanticscholar.org/paper/8d0b2a68b4390f203977787078ef9d60f3b801